MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Hold...(HREF mailto:kkamsler@minrad.com kkamsler...),Health
HREF="mailto:kkamsler@minrad.com">kkamsler@minrad.com
Charles R. Trego, Jr., Executive Vice President & Chief
Financial Officer
(716) 855-1068
About the Company
MINRAD International, Inc. is an interventional pain management company with real-time image guidance, anesthesia and analgesia, conscious sedation product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company's website, http://www.minrad.com.
The information contained in this news release, other than historical
information, consists of forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These statements may
involve risks and uncertainties that could cause actual results to differ
materially from those described in such statements. Factors that may cause
actual results to differ materially from those expressed or implied by its
forward-looking statements include, but are not limited to, Minrad
International's limited operating history and business development
associated with being a growth stage com
'/>"/>
| SOURCE MINRAD International, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. MINRAD International, Inc. Announces 2007 Financial Results
5. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
6. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
7. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
8. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
9. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
10. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
11. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |